|
1
|
Islami F, Torre LA and Jemal A: Global
trends of lung cancer mortality and smoking prevalence. Transl Lung
Cancer Res. 4:327–338. 2015.PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin
C and Flavell RA: Inflammation-induced cancer: Crosstalk between
tumours, immune cells and microorganisms. Nat Rev Cancer.
13:759–771. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dvorak HF: Tumors: Wounds that do not
heal. Similarities between tumor stroma generation and wound
healing. N Engl J Med. 315:1650–1659. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pálmai-Pallag T and Bachrati CZ:
Inflammation-induced DNA damage and damage-induced inflammation: A
vicious cycle. Microbes Infect. 16:822–832. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu S and Cao X: Interleukin-17 and its
expanding biological functions. Cell Mol Immunol. 7:164–174. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yao Z, Fanslow WC, Seldin MF, Rousseau AM,
Painter SL, Comeau MR, Cohen JI and Spriggs MK: Herpesvirus Saimiri
encodes a new cytokine, IL-17, which binds to a novel cytokine
receptor. Immunity. 3:811–821. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rouvier E, Luciani MF, Mattéi MG, Denizot
F and Golstein P: CTLA-8, cloned from an activated T cell, bearing
AU-rich messenger RNA instability sequences, and homologous to a
herpesvirus saimiri gene. J Immunol. 150:5445–5456. 1993.PubMed/NCBI
|
|
13
|
Iwakura Y, Ishigame H, Saijo S and Nakae
S: Functional specialization of interleukin-17 family members.
Immunity. 34:149–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cua DJ and Tato CM: Innate IL-17-producing
cells: The sentinels of the immune system. Nat Rev Immunol.
10:479–489. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aggarwal S, Ghilardi N, Xie MH, de Sauvage
FJ and Gurney AL: Interleukin-23 promotes a distinct CD4 T cell
activation state characterized by the production of interleukin-17.
J Biol Chem. 278:1910–1914. 2003. View Article : Google Scholar
|
|
16
|
Zhong F, Cui D, Tao H, Du H and Xing C:
IL-17A-producing T cells and associated cytokines are involved in
the progression of gastric cancer. Oncol Rep. 34:2365–2374.
2015.PubMed/NCBI
|
|
17
|
Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X,
Shi L, Wu D, Dong C and Liu H: IL-17A produced by γδ T cells
promotes tumor growth in hepatocellular carcinoma. Cancer Res.
74:1969–1982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coffelt SB, Kersten K, Doornebal CW,
Weiden J, Vrijland K, Hau CS, Verstegen NJ, Ciampricotti M,
Hawinkels LJ, Jonkers J, et al: IL-17-producing γδ T cells and
neutrophils conspire to promote breast cancer metastasis. Nature.
522:345–348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, Liu S, Ge D, Zhang Q, Xue Y,
Xiong Z, Abdel-Mageed AB, Myers L, Hill SM, Rowan BG, et al:
Interleukin-17 promotes formation and growth of prostate
adenocarcinoma in mouse models. Cancer Res. 72:2589–2599. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Silva-Santos B, Serre K and Norell H: γδ T
cells in cancer. Nat Rev Immunol. 15:683–691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patil RS, Bhat SA, Dar AA and Chiplunkar
SV: The Jekyll and Hyde story of IL17-producing γδT cells. Front
Immunol. 6:372015. View Article : Google Scholar
|
|
22
|
Wang K and Karin M: The IL-23 to IL-17
cascade inflammation-related cancers. Clin Exp Rheumatol. 33(Suppl
92): S87–S90. 2015.PubMed/NCBI
|
|
23
|
Shalapour S and Karin M: Immunity,
inflammation, and cancer: An eternal fight between good and evil. J
Clin Invest. 125:3347–3355. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hemdan NY: Anti-cancer versus
cancer-promoting effects of the interleukin-17-producing T helper
cells. Immunol Lett. 149:123–133. 2013. View Article : Google Scholar
|
|
25
|
Kryczek I, Wei S, Szeliga W, Vatan L and
Zou W: Endogenous IL-17 contributes to reduced tumor growth and
metastasis. Blood. 114:357–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martin-Orozco N, Muranski P, Chung Y, Yang
XO, Yamazaki T, Lu S, Hwu P, Restifo NP, Overwijk WW and Dong C: T
helper 17 cells promote cytotoxic T cell activation in tumor
immunity. Immunity. 31:787–798. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu B, Guenther JF, Pociask DA, Wang Y,
Kolls JK, You Z, Chandrasekar B, Shan B, Sullivan DE and Morris GF:
Promotion of lung tumor growth by interleukin-17. Am J Physiol Lung
Cell Mol Physiol. 307:L497–L508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang SH, Mirabolfathinejad SG, Katta H,
Cumpian AM, Gong L, Caetano MS, Moghaddam SJ and Dong C: T helper
17 cells play a critical pathogenic role in lung cancer. Proc Natl
Acad Sci USA. 111:5664–5669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Wan J, Liu J, Xie W, Diao X, Xu J,
Zhu B and Chen Z: Increased IL-17-producing cells correlate with
poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer.
69:348–354. 2010. View Article : Google Scholar
|
|
30
|
Yang G, Li H, Yao Y, Xu F, Bao Z and Zhou
J: Treg/Th17 imbalance in malignant pleural effusion partially
predicts poor prognosis. Oncol Rep. 33:478–484. 2015.
|
|
31
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee; et al: The IASLC Lung Cancer
Staging Project: proposals for the revision of the TNM stage
groupings in the forthcoming (seventh) edition of the TNM
Classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muranski P and Restifo NP: Essentials of
Th17 cell commitment and plasticity. Blood. 121:2402–2414. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage
distinct from the T helper type 1 and 2 lineages. Nat Immunol.
6:1123–1132. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ye J, Livergood RS and Peng G: The role
and regulation of human Th17 cells in tumor immunity. Am J Pathol.
182:10–20. 2013. View Article : Google Scholar :
|
|
35
|
Guéry L and Hugues S: Th17 Cell plasticity
and functions in cancer Immunity. Biomed Res Int. 2015:3146202015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang JP, Yan J, Xu J, Pang XH, Chen MS,
Li L, Wu C, Li SP and Zheng L: Increased intratumoral
IL-17-producing cells correlate with poor survival in
hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Q, Li Q, Chen J, Liu Y, Zhao X, Tan B,
Ai J, Zhang Z, Song J and Shan B: Prevalence of Th17 and Treg cells
in gastric cancer patients and its correlation with clinical
parameters. Oncol Rep. 30:1215–1222. 2013.PubMed/NCBI
|
|
38
|
Chen WC, Lai YH, Chen HY, Guo HR, Su IJ
and Chen HH: Interleukin-17-producing cell infiltration in the
breast cancer tumour microenvironment is a poor prognostic factor.
Histopathology. 63:225–233. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF and
Peng G: Tumor microenvironments direct the recruitment and
expansion of human Th17 cells. J Immunol. 184:1630–1641. 2010.
View Article : Google Scholar
|
|
40
|
Shan M, Yuan X, Song LZ, Roberts L,
Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C,
et al: Cigarette smoke induction of osteopontin (SPP1) mediates
TH17 inflammation in human and experimental emphysema. Sci Transl
Med. 4:117ra92012. View Article : Google Scholar
|
|
41
|
Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin
JB, Tao XN and Shi HZ: Generation and differentiation of
IL-17-producing CD4+ T cells in malignant pleural
effusion. J Immunol. 185:6348–6354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li S, Li Y, Qu X, Liu X and Liang J:
Detection and significance of TregFoxP3+ and Th17 cells
in peripheral blood of non-small cell lung cancer patients. Arch
Med Sci. 10:232–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liang Y, Pan HF and Ye DQ: Tc17 cells in
immunity and systemic autoimmunity. Int Rev Immunol. 34:318–331.
2015. View Article : Google Scholar
|
|
44
|
Kondo T, Takata H, Matsuki F and Takiguchi
M: Cutting edge: Phenotypic characterization and differentiation of
human CD8+ T cells producing IL-17. J Immunol.
182:1794–1798. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY,
Wang J, Yin XY, Li L and Zheng L: Tumor-activated monocytes promote
expansion of IL-17-producing CD8+ T cells in
hepatocellular carcinoma patients. J Immunol. 185:1544–1549. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang Y, Hou F, Liu X, Ma D, Zhang Y, Kong
B and Cui B: Tc17 cells in patients with uterine cervical cancer.
PLoS One. 9:e868122014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu Y, Cho HI, Wang D, Kaosaard K, Anasetti
C, Celis E and Yu XZ: Adoptive transfer of Tc1 or Tc17 cells
elicits antitumor immunity against established melanoma through
distinct mechanisms. J Immunol. 190:1873–1881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Garcia-Hernandez ML, Hamada H, Reome JB,
Misra SK, Tighe MP and Dutton RW: Adoptive transfer of
tumor-specific Tc17 effector T cells controls the growth of B16
melanoma in mice. J Immunol. 184:4215–4227. 2010. View Article : Google Scholar
|
|
49
|
Nelson MH, Kundimi S, Bowers JS, Rogers
CE, Huff LW, Schwartz KM, Thyagarajan K, Little EC, Mehrotra S,
Cole DJ, et al: The inducible costimulator augments Tc17 cell
responses to self and tumor tissue. J Immunol. 194:1737–1747. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Banat GA, Tretyn A, Pullamsetti SS,
Wilhelm J, Weigert A, Olesch C, Ebel K, Stiewe T, Grimminger F,
Seeger W, et al: Immune and inflammatory cell composition of human
lung cancer stroma. PLoS One. 10:e01390732015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jiang G, Ma S, Wei Y, Wu Y, Yu X and Liu
H: The prevalence and distribution of Th17 and Tc17 cells in
patients with thyroid tumor. Immunol Lett. 162:68–73. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Vantourout P and Hayday A:
Six-of-the-best: Unique contributions of γδ T cells to immunology.
Nat Rev Immunol. 13:88–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rei M, Pennington DJ and Silva-Santos B:
The emerging protumor role of γδ T lymphocytes: Implications for
cancer immunotherapy. Cancer Res. 75:798–802. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, Wang
Z, Wang C, Zhang Z, Xia W, et al: γδT17 cells promote the
accumulation and expansion of myeloid-derived suppressor cells in
human colorectal cancer. Immunity. 40:785–800. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rei M, Gonçalves-Sousa N, Lança T,
Thompson RG, Mensurado S, Balkwill FR, Kulbe H, Pennington DJ and
Silva-Santos B: Murine CD27− Vγ6+ γδ T cells
producing IL-17A promote ovarian cancer growth via mobilization of
protumor small peritoneal macrophages. Proc Natl Acad Sci USA.
111:E3562–E3570. 2014. View Article : Google Scholar
|
|
56
|
Bystrom J, Taher TE, Muhyaddin MS, Clanchy
FI, Mangat P, Jawad AS, Williams RO and Mageed RA: Harnessing the
therapeutic potential of Th17 cells. Mediators Inflamm.
2015:2051562015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Langowski JL, Zhang X, Wu L, Mattson JD,
Chen T, Smith K, Basham B, McClanahan T, Kastelein RA and Oft M:
IL-23 promotes tumour incidence and growth. Nature. 442:461–465.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
He D, Li H, Yusuf N, Elmets CA, Li J,
Mountz JD and Xu H: IL-17 promotes tumor development through the
induction of tumor promoting microenvironments at tumor sites and
myeloid-derived suppressor cells. J Immunol. 184:2281–2288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chung AS, Wu X, Zhuang G, Ngu H, Kasman I,
Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV, et al: An
interleukin-17-mediated paracrine network promotes tumor resistance
to anti-angiogenic therapy. Nat Med. 19:1114–1123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yang B, Kang H, Fung A, Zhao H, Wang T and
Ma D: The role of interleukin 17 in tumour proliferation,
angiogenesis, and metastasis. Mediators Inflamm. 2014:6237592014.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lo Re S, Dumoutier L, Couillin I, Van Vyve
C, Yakoub Y, Uwambayinema F, Marien B, van den Brûle S, Van Snick
J, Uyttenhove C, et al: IL-17A-producing gammadelta T and Th17
lymphocytes mediate lung inflammation but not fibrosis in
experimental silicosis. J Immunol. 184:6367–6377. 2010. View Article : Google Scholar : PubMed/NCBI
|
